Blogs

GlaxoSmithKline and Cerebras are Advancing the State of the Art in AI for Drug Discovery - Cerebras

Cerebras

Kim Branson, SVP & Global Head of Artificial Intelligence and Machine Learning, Meredith Trotter, and Stephen Young, GSK.

Visit Site

GlaxoSmithKline and Cerebras are Advancing the State of the Art in AI for Drug Discovery - Cerebras
Visualizing Knowledge at Lightning Speed with Cerebras at Tako - CerebrasCerebras Breaking the Boundaries of Presence: Delphi's Digital Mind TechnologyCerebras Training Multi-Billion-Parameter Models on a Single Cerebras System is Easy - CerebrasCerebras Revolutionizing Life Science and Healthcare with Generative AI - CerebrasCerebras Cerebras Breaks Exascale Record for Molecular Dynamics Simulations - CerebrasCerebras The rise of slow personal assistantsCerebras State of Speech: Our New Data Report Reveals ASR’s Untapped Potential - Deepgram Blog ⚡️Deepgram Svelte for the Experienced React DevCss Tricks Best Documentation Platforms for AI Agents in 2026Mintlify Speech-to-Text API model for Pharma Use Cases | Nova-3 PharmaDeepgram Announcing OpenAPI support for the Pulumi Cloud REST APIPulumi Memory snapshots: Checkpoint/restore for sub-second startupModal State of DevSecOpsDatadoghq State of Cloud SecurityDatadoghq Docker State of App Dev - Dev Ex & ProductivityDocker What is Prompt Engineering? - Deepgram Blog ⚡️Deepgram Whack-a-Mole: The CSS EditionCss Tricks Context is Everything: Why Maximum Sequence Length Matters - CerebrasCerebras Docker State of App Dev: AIDocker The state of enterprise video 2026: Ambition vs. realityHeygen